Neoepitopes of Cancers: Looking Back, Looking Ahead

Area of Science:

• Cancer immunology
• Genomics
• Immunotherapy

Background:

• The quest for cancer-specific targets has been a long-standing goal in cancer immunology.
• Cancers possess unique mutations, and the immune system can recognize these cancer-specific antigens.
• Technological progress is now bridging genetics and immunology to study cancer.

Purpose of the Study:

• To investigate which cancer-specific genetic alterations are recognized by the immune system.
• To understand the reasons behind immune recognition of specific cancer mutations.
• To inform the next wave of human cancer immunotherapy studies.

Main Methods:

• High-throughput DNA sequencing
• Bioinformatics analysis
• Analysis of cancer-specific genomic alterations and immune recognition

Main Results:

• Human cancers exhibit significant genetic differences compared to normal tissues.
• Some of these genetic differences are recognized by the immune system.
• New research is providing high-resolution insights into these cancer-immune interactions.

Conclusions:

• The genetic landscape of cancer offers potential targets for immunotherapy.
• Understanding immune recognition of cancer mutations is crucial for developing effective cancer treatments.
• Converging genetic and immunologic data are paving the way for novel cancer immunotherapies.